Effects of a Nordic breakfast on cardiovascular risk factors.

ISRCTN ISRCTN84550872
DOI https://doi.org/10.1186/ISRCTN84550872
Secondary identifying numbers North B U-08-017
Submission date
04/12/2009
Registration date
07/01/2010
Last edited
14/05/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Ulf Riserus
Scientific

Clinical Nutrition and Metabolism
Department of Public Health and Caring Sciences
Uppsala Science Park
Uppsala
751 85
Sweden

Study information

Study designRandomised controlled parallel group intervention study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typePrevention
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEffects of a Nordic breakfast diet on risk markers for cardiovascular disease in healthy mildly hypercholesterolemic men and women.
Study acronymNorth B
Study objectivesThe aim of this study is to investigate if intake of a healthy Nordic breakfast may affect risk markers for cardiovascular disease in healthy mildly hypercholesterolemic men and women.
Ethics approval(s)The study was approved by the regional ethic committee in Uppsala, on the 20th of January 2009 (ref: North B U-08-017, Dnr 2009/018)
Health condition(s) or problem(s) studiedCardiovascular risk factors
InterventionThe test breakfast will include: Porridge made of oat bran. Low fat milk or yoghurt. A choice of jam (blueberries or lingonberries). Whole grain bread. Margarine with high content of polyunsaturated fatty acids (19%). Something to put on the bread such as low fat meat or pickled herring or mackerel in tomato. Fresh fruit will also be included.

Outcomes after intake of a Nordic breakfast diet in comparison to ordinary foods in mildly hypercholesterolemic men and women, (LDL-cholesterol levels > 3.0 mmol/l) will be measured after 12 weeks. There will be no follow up beyond the end of the 12 week intervention.
Intervention typeOther
Primary outcome measureThe effect on LDL-cholesterol will be measured at baseline, 6 and 12 weeks.
Secondary outcome measuresThe following will be measured at baseline, 6 and 12 weeks
1. HDL cholesterol
2. Total cholesterol
3. Triglycerides
4. High-Sensitivity C-Reactive Protein (HS-CRP)
5. Apolipoprotein A1 and B
6. Blood pressure
7. Sagittal abdominal diameter (SAG)
8. Hip
9. Waist
10. Glycated Haemoglobin (HbA1c)
The following will be measured at baseline and 12 weeks
11. Glucose response
12. Insulin sensitivity
Overall study start date01/06/2009
Completion date30/01/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants88
Key inclusion criteria1. Slightly overweight and hyperlipidemic but otherwise healthy as assessed by the results of the screening laboratory tests and judged by medical staff
2. Age ≥ 25 and ≤ 67 years at visit 1
3. Body Mass Index (BMI) ≥ 25 and ≤ 35 kg/m2
4. LDL cholesterol ≥ 3.0 mmol/l
5. Haemoglobin (Hb) ≥ 120 g/l for women and ≥ 130 g/l for men
6. Signed written informed and biobank consents
Key exclusion criteria1. Participation in a clinical study with blood sampling within 90 days prior to screening visit and throughout the study.
2. Use of cholesterol lowering medication <3 months prior screening visit.
3. Blood pressure >155/95 (will be measured at visit 1 for inclusion).
4. Consumption of products or supplements fortified with plant sterols or omega-3 or omega-6 or omega 9- fatty acids within 3 weeks prior to the visit 1 and no consumption at all throughout the study.
5. Allergic to certain foods
6. Slimming or medically prescribed diet/medication or a special diet (vegan and gluten-free).
7. Not able to eat porridge for breakfast every day during 12 weeks
8. Not able to eat herring or mackerel for breakfast 3 days/week during 12 weeks
9. Pregnant or lactating or wish to become pregnant during the period of the study.
10. Lack of suitability for participation in the study for any reason as judged by the personnel at Good Food Practice (GFP) research clinic.
Date of first enrolment01/06/2009
Date of final enrolment30/01/2010

Locations

Countries of recruitment

  • Sweden

Study participating centre

Clinical Nutrition and Metabolism
Uppsala
751 85
Sweden

Sponsor information

University of Uppsala (Sweden)
University/education

Clinical Nutrition and Metabolism
Departement of Public health and Caring Sciences
Uppsala Science Park
Uppsala
751 85
Sweden

ROR logo "ROR" https://ror.org/048a87296

Funders

Funder type

Industry

Cerealia Foundation R&D (Sweden)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/02/2015 Yes No